Navigation Links
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Date:7/15/2009

Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.

    For further information please contact:

    Investor Relations
    Clea Rosenfeld (Rest of the World), +44-1256-894-160
    Eric Rojas (North America), +1-617-551-9715

    Media
    Jessica Mann (Rest of the World), +44-1256-894-280
    Matt
'/>"/>
SOURCE  Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related medicine technology :

1. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
2. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
3. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
4. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
5. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
6. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
7. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
8. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
9. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
10. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
11. USC Keck School of Medicines Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
(Date:5/23/2013)... -- More than half of women diagnosed with early ... still have excellent outcomes. To educate women, Agendia, Inc. ... sources of online consumer information about breast cancer genomic ... recently diagnosed women with information sources, to help them ... "We anticipate these innovative social media campaigns will encourage ...
(Date:5/23/2013)... , May 23, 2013 Anthem Blue ... that would have required them to obtain their medications ... Consumer Watchdog and Whatley Kallas LLC.  ... Court, alleged that Blue Cross,s mandatory mail order program ... their health and privacy. "This settlement brings ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
(Date:5/25/2013)... (PRWEB) May 25, 2013 Life science ... are used to detect and create a new substance ... reading and are also known as biotechnology reagents. Such ... diagnosis and education. , This market is driven by ... in the field of therapeutics, growth in research and ...
(Date:5/25/2013)... New York, New York (PRWEB) May 25, 2013 ... a federal multidistrict litigation underway in U.S. District Court, ... Liebhard LLP reports. According to a Case Management ... procedures that govern the filing of contested motions in ... for filing those motions. (In re: Actos Product Liability ...
(Date:5/25/2013)... May 25, 2013 The report ... By Types, Functions, Applications, Ingredients, Shell Materials, Packaging, ... the global food encapsulation market with analysis and ... It also identifies the driving and restraining factors ... of trends, opportunities, and challenges. The market is ...
(Date:5/25/2013)... MO (PRWEB) May 25, 2013 Providing patients ... the Diet Doc team of weight management professionals. But, aside ... and effectively, Diet Doc’s hCG diets also ... like abuse during childhood like bullying, more control over their ... capable of dealing with the underlying factors of weight gain ...
(Date:5/25/2013)... Pradaxa lawsuits filed on behalf ... bleeding while using the blood thinner continue to mount in ... of Illinois, Bernstein Liebhard LLP reports. According to a ... had been filed in the litigation as of ... by the Court on May 15th. ( In Re: Pradaxa ...
Breaking Medicine News(10 mins):Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3
... Research Group, Inc. released TreatmentTrends(R): US Nephrology, a syndicated ... US Nephrologists.In the ESA market, changes that have occurred ... while the overall use of ESAs has remained stable ... patients with Chronic Kidney Disease not on dialysis (CKD), ...
... Mexico, April 27 Grupo Aeroportuario del Pacifico, S.A.B. de ... or "GAP" today announced the following:On Sunday, April 26, 2009, ... A and B viruses in humans as well as the ... (Swine Flu Virus). As a result of the alerts, the ...
... - On Tuesday, April 28, at 10:00 a.m., Donate Life, ... donors, and family members of organ ... Sacramento area firefighters at the California Firefighters, ... by Senator George Runner and Senator ...
... sudden and near-constant stream of news reports about swine ... These reactions are understandable because circumstances are rapidly evolving ... during this period of uncertainty, you can take several ... outlook. The American Psychological Association has useful information and ...
... Innovations, Inc. (Nasdaq: YDNT ) today announced results ... the first quarter of 2009 were $23.8 million, a decrease ... in the first quarter of 2008. Income from operations increased ... from $4.6 million in the first quarter of 2008. Net ...
... April 27 Hanger Orthopedic Group, Inc. (NYSE: ... quarter ended March 31, 2009, an increase of $11.4 million, ... Net income increased $0.9 million, or 26.6%, to $4.5 million ... year. Net income applicable to common stock in the ...
Cached Medicine News:Health News:Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group 2Health News:Grupo Aeroportuario del Pacifico, S.A.B. de C.V. Announcement Regarding Swine Flu Virus 2Health News:Grupo Aeroportuario del Pacifico, S.A.B. de C.V. Announcement Regarding Swine Flu Virus 3Health News:Donate Life California to Hold Press Conference Commemorating Donation Heroes Tuesday, April 28, 10:00 a.m., State Capitol 2Health News:APA Offers Tips on Managing Anxiety About Swine Flu 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009 3Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009 4Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009 5Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009 6Health News:Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009 2Health News:Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009 3Health News:Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009 4Health News:Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009 5Health News:Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009 6
Blood sedimentation rate analysis...
... speed and precision in a flexible ... technology. With its advanced design, ... to 300 samples or 500 tests ... This high performance, fully automated analyzer ...
... lancing device that has set the standard ... This re-usable lancing device assists in obtaining ... is constructed in the USA of durable ... year after year. It's the only lancing ...
... of testing. Unlike conventional lancing systems, the ... one with a six-lancet drum. It offers ... and improved safety. With 11 depth settings ... for less skin tearing, over 90% of ...
Medicine Products: